The genotype-phenotype association of CYP3A4 and CYP3A5 polymorphisms to midazolam clearance in vivo

被引：0
|
作者：
He, P [1 ]
Court, MH [1 ]
Greenblatt, DJ [1 ]
von Moltke, LL [1 ]
机构：
[1] Tufts Univ, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2004年 / 44卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
103
引用
收藏
页码：1209 / 1209
页数：1
相关论文
共 50 条
  • [1] The genotype-phenotype association of CYP3A4 and CYP3A5 polymorphisms to midazolam hydroxylation in vivo
    He, P
    Court, MH
    Greenblatt, DJ
    von Moltke, LL
    DRUG METABOLISM REVIEWS, 2004, 36 : 118 - 118
  • [2] GLOBAL ANALYSIS OF CYP3A4 AND CYP3A5 GENOTYPE ON IN VIVO CLEARANCE OF CYP3A4 SUBSTRATES.
    Quinney, S. K.
    Schwartz, J. B.
    Hall, S. D.
    Gorski, J. C.
    Li, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S49 - S49
  • [3] Genotype-phenotype analysis confirms polymorphic expression of CYP3A5 exceeding CYP3A4 in kidneys of Caucasian individuals
    Schaller, S.
    Herrlinger, F.
    Kempkensteffen, C.
    Schostak, M.
    Kreutz, R.
    Bolbrinker, J.
    JOURNAL OF HYPERTENSION, 2008, 26 : S145 - S145
  • [4] Genotype-phenotype associations of CYP3A5 polymorphisms on carbamazepine pharmacokinetics in the patients
    Prasittisopin, Baralee
    Cloyd, James C.
    Marino, Susan E.
    Brundage, Richard C.
    Ramsay, R. E.
    Pennell, P. B.
    Oetting, William S.
    Rarick, John O.
    Mishra, Usha
    Beattie, Jeanne
    Leppik, Ilo E.
    Birnbaum, Angela K.
    NEUROLOGY, 2007, 68 (12) : A126 - A127
  • [5] Screening of Genetic Polymorphisms of CYP3A4 and CYP3A5 Genes
    Leel, Jin Sol
    Cheong, Hyun Sub
    Kim, Lyoung Hyo
    Kixn, Ji On
    Seo, Doo Won
    Kim, Young Hoon
    Chung, Myeon Woo
    Han, Soon Young
    Shin, Hyoung Doo
    KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, 2013, 17 (06): : 479 - 484
  • [6] Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population
    Islam, Mohammad Safiqul
    Mostofa, A. G. M.
    Ahmed, Maizbha Uddin
    Bin Sayeed, Muhammad Shahdaat
    Hassan, Md. Rajib
    Hasnat, Abul
    TUMOR BIOLOGY, 2014, 35 (02) : 1671 - 1678
  • [7] THE INFLUENCE OF CYP3A4 AND CYP3A5 GENOTYPE AND PHENOTYPE ON THE PHARMACOKINETICS OF TACROLIMUS IN HEALTHY CHINESE.
    Jiao, Z.
    Shi, X.
    Geng, F.
    Cui, X.
    Qiu, X.
    Zhong, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S52 - S52
  • [8] Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women
    Floyd, MD
    Gervasini, G
    Masica, AL
    Mayo, G
    George, AL
    Bhat, K
    Kim, RB
    Wilkinson, GR
    PHARMACOGENETICS, 2003, 13 (10): : 595 - 606
  • [9] Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms
    Riffi, Rachda
    Boughrara, Wefa
    Chentouf, Amina
    Ilias, Wassila
    Brahim, Narimene Malika Taieb
    Berrebbah, Amel Alioua
    Belhoucine, Fatma
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2024, 23 (12) : 1463 - 1473
  • [10] In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Hematocrit Predict Tacrolimus Dose Requirements and Clearance in Renal Transplant Patients
    de Jonge, H.
    de Loor, H.
    Verbeke, K.
    Vanrenterghem, Y.
    Kuypers, D. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 366 - 375
12345